Skip to main content

Chads2 Score Calculator

Calculate the CHADS2 stroke risk score for patients with non-valvular atrial fibrillation. Enter values for instant results with step-by-step formulas.

Skip to calculator
Clinical Medicine

Chads2 Score Calculator

Calculate the CHADS2 stroke risk score for patients with non-valvular atrial fibrillation. Get annual stroke rate and anticoagulation recommendations.

Last updated: January 2026Reviewed by NovaCalculator Medical Editorial Team

Calculator

Adjust values & calculate

For clinical decision support only. Always consult current guidelines and clinical judgment.

C โ€” Congestive Heart Failure
History of CHF or LVEF โ‰ค 40%
+1
H โ€” Hypertension
BP > 140/90 mmHg or on antihypertensive
+1
A โ€” Age โ‰ฅ 75
Patient is 75 years old or older
+1
D โ€” Diabetes Mellitus
Fasting glucose > 125 mg/dL or on treatment
+1
Sโ‚‚ โ€” Prior Stroke / TIA
History of stroke, TIA, or thromboembolism
+2
CHADS2 Score
0
Low Risk

Clinical Interpretation

Annual Stroke Rate1.9%
RecommendationAspirin (75-325 mg daily) or no antithrombotic therapy.

Stroke Rate by Score

Score 01.9% / year
Score 12.8% / year
Score 24% / year
Score 35.9% / year
Score 48.5% / year
Score 512.5% / year
Score 618.2% / year
Your Result
CHADS2 = 0 | Risk: Low | Annual Stroke Rate: 1.9%
Share Your Result
Understand the Math

Formula

CHADS2 = C + H + A + D + S2

Each risk factor scores 1 point (CHF, Hypertension, Age โ‰ฅ75, Diabetes) except prior Stroke/TIA which scores 2 points. Total ranges from 0-6. Higher scores indicate greater annual stroke risk.

Last reviewed: January 2026

Worked Examples

Example 1: Elderly Patient with Hypertension and Diabetes

A 78-year-old patient with atrial fibrillation has hypertension and type 2 diabetes. No history of stroke or heart failure. Calculate the CHADS2 score.
Solution:
C (CHF) = 0 H (Hypertension) = 1 A (Age โ‰ฅ75) = 1 D (Diabetes) = 1 S2 (Stroke/TIA) = 0 Total CHADS2 = 0 + 1 + 1 + 1 + 0 = 3 Annual stroke risk: ~5.9%
Result: CHADS2 = 3 | Risk: Moderate-High | Annual stroke rate: 5.9% | Oral anticoagulant recommended

Example 2: Young Patient with Prior Stroke

A 62-year-old patient with AF has a history of prior TIA but no other risk factors. Calculate the CHADS2 score.
Solution:
C (CHF) = 0 H (Hypertension) = 0 A (Age โ‰ฅ75) = 0 D (Diabetes) = 0 S2 (Stroke/TIA) = 2 Total CHADS2 = 0 + 0 + 0 + 0 + 2 = 2 Annual stroke risk: ~4.0%
Result: CHADS2 = 2 | Risk: Moderate | Annual stroke rate: 4.0% | Anticoagulation recommended
Expert Insights

Background & Theory

The Chads2 Score Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/mยฒ), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 ร— weight in kg) + (6.25 ร— height in cm) โˆ’ (5 ร— age) ยฑ sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.

History

The history behind the Chads2 Score Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.

Share this calculator

Explore More

Frequently Asked Questions

The CHADS2 score is a clinical prediction tool used to estimate the risk of stroke in patients with non-valvular atrial fibrillation (AF). It was developed by Brian Gage and colleagues and published in 2001. The acronym stands for Congestive heart failure, Hypertension, Age 75 or older, Diabetes mellitus, and prior Stroke or TIA (which receives 2 points, hence the subscript 2). The score ranges from 0 to 6, with higher scores indicating greater annual stroke risk. It helps clinicians decide whether to prescribe anticoagulation therapy. The CHADS2 score has been widely validated in multiple populations and remains a simple, practical tool for initial stroke risk stratification in atrial fibrillation patients.
The CHADS2 score is calculated by assigning points for each risk factor present: Congestive heart failure (1 point) for a history of heart failure or reduced left ventricular ejection fraction; Hypertension (1 point) for blood pressure consistently above 140/90 mmHg or currently on antihypertensive medication; Age 75 years or older (1 point); Diabetes mellitus (1 point) for fasting glucose above 125 mg/dL or on hypoglycemic treatment; and Stroke or TIA history (2 points) for any prior cerebrovascular event. The total score ranges from 0 to 6. Each point increase corresponds to a significant increase in annual stroke risk, from approximately 1.9% at score 0 to 18.2% at score 6.
The CHA2DS2-VASc score is an updated and more refined version of the CHADS2 score. While CHADS2 has 5 risk factors totaling a maximum of 6 points, CHA2DS2-VASc adds three additional factors: Vascular disease (prior MI, peripheral artery disease, or aortic plaque), Age 65-74 (1 point), and Sex category (female sex, 1 point), while Age 75 or older receives 2 points instead of 1. CHA2DS2-VASc ranges from 0 to 9 and is better at identifying truly low-risk patients who can safely avoid anticoagulation. Current guidelines from the European Society of Cardiology preferentially recommend CHA2DS2-VASc, though CHADS2 remains widely used due to its simplicity and extensive validation.
Anticoagulation recommendations based on CHADS2 score generally follow these guidelines: Score 0 indicates low risk (approximately 1.9% annual stroke rate), and aspirin alone (75-325 mg daily) or no therapy may be appropriate. Score 1 represents moderate risk (2.8% annual rate), where either aspirin or oral anticoagulation can be considered based on patient preference and bleeding risk. Score 2 or higher indicates that oral anticoagulation is recommended unless contraindicated, as the annual stroke risk exceeds 4%. Options include warfarin (target INR 2.0-3.0) or direct oral anticoagulants (DOACs) such as apixaban, rivarelbaan, dabigatran, or edoxaban. The bleeding risk (assessed with HAS-BLED score) should always be weighed against the stroke prevention benefit.
The CHADS2 score has several recognized limitations. First, it classifies a large proportion of patients as intermediate risk (score 1), making treatment decisions uncertain for this group. Second, it does not account for several important stroke risk factors including vascular disease, age 65-74, and female sex, which are captured by the CHA2DS2-VASc score. Third, all included risk factors are weighted equally (except stroke), despite evidence that some factors carry higher risk than others. Fourth, it was validated primarily in North American and European populations and may not perform equally across all ethnic groups. Fifth, it does not incorporate bleeding risk assessment, so clinicians must separately evaluate contraindications to anticoagulation. Despite these limitations, its simplicity makes it useful for rapid bedside risk stratification.
You may use the results for reference and educational purposes. For professional reports, academic papers, or critical decisions, we recommend verifying outputs against peer-reviewed sources or consulting a qualified expert in the relevant field.
Educational Note: This calculator is provided for educational and informational purposes. Results are based on the formulas and inputs provided. Always verify important calculations independently. NovaCalculator processes calculator inputs client-side; optional analytics follow visitor consent settings.Reviewed by: NovaCalculator Medical Editorial Team โ€” Reviewed against WHO, NIH, and peer-reviewed clinical sources. Last reviewed: January 2026. ยฉ 2024โ€“2026 NovaCalculator.

Share this calculator

Formula

CHADS2 = C + H + A + D + S2

Each risk factor scores 1 point (CHF, Hypertension, Age โ‰ฅ75, Diabetes) except prior Stroke/TIA which scores 2 points. Total ranges from 0-6. Higher scores indicate greater annual stroke risk.

Worked Examples

Example 1: Elderly Patient with Hypertension and Diabetes

Problem: A 78-year-old patient with atrial fibrillation has hypertension and type 2 diabetes. No history of stroke or heart failure. Calculate the CHADS2 score.

Solution: C (CHF) = 0\nH (Hypertension) = 1\nA (Age โ‰ฅ75) = 1\nD (Diabetes) = 1\nS2 (Stroke/TIA) = 0\nTotal CHADS2 = 0 + 1 + 1 + 1 + 0 = 3\nAnnual stroke risk: ~5.9%

Result: CHADS2 = 3 | Risk: Moderate-High | Annual stroke rate: 5.9% | Oral anticoagulant recommended

Example 2: Young Patient with Prior Stroke

Problem: A 62-year-old patient with AF has a history of prior TIA but no other risk factors. Calculate the CHADS2 score.

Solution: C (CHF) = 0\nH (Hypertension) = 0\nA (Age โ‰ฅ75) = 0\nD (Diabetes) = 0\nS2 (Stroke/TIA) = 2\nTotal CHADS2 = 0 + 0 + 0 + 0 + 2 = 2\nAnnual stroke risk: ~4.0%

Result: CHADS2 = 2 | Risk: Moderate | Annual stroke rate: 4.0% | Anticoagulation recommended

Frequently Asked Questions

What is the CHADS2 score?

The CHADS2 score is a clinical prediction tool used to estimate the risk of stroke in patients with non-valvular atrial fibrillation (AF). It was developed by Brian Gage and colleagues and published in 2001. The acronym stands for Congestive heart failure, Hypertension, Age 75 or older, Diabetes mellitus, and prior Stroke or TIA (which receives 2 points, hence the subscript 2). The score ranges from 0 to 6, with higher scores indicating greater annual stroke risk. It helps clinicians decide whether to prescribe anticoagulation therapy. The CHADS2 score has been widely validated in multiple populations and remains a simple, practical tool for initial stroke risk stratification in atrial fibrillation patients.

How is the CHADS2 score calculated?

The CHADS2 score is calculated by assigning points for each risk factor present: Congestive heart failure (1 point) for a history of heart failure or reduced left ventricular ejection fraction; Hypertension (1 point) for blood pressure consistently above 140/90 mmHg or currently on antihypertensive medication; Age 75 years or older (1 point); Diabetes mellitus (1 point) for fasting glucose above 125 mg/dL or on hypoglycemic treatment; and Stroke or TIA history (2 points) for any prior cerebrovascular event. The total score ranges from 0 to 6. Each point increase corresponds to a significant increase in annual stroke risk, from approximately 1.9% at score 0 to 18.2% at score 6.

What is the difference between CHADS2 and CHA2DS2-VASc?

The CHA2DS2-VASc score is an updated and more refined version of the CHADS2 score. While CHADS2 has 5 risk factors totaling a maximum of 6 points, CHA2DS2-VASc adds three additional factors: Vascular disease (prior MI, peripheral artery disease, or aortic plaque), Age 65-74 (1 point), and Sex category (female sex, 1 point), while Age 75 or older receives 2 points instead of 1. CHA2DS2-VASc ranges from 0 to 9 and is better at identifying truly low-risk patients who can safely avoid anticoagulation. Current guidelines from the European Society of Cardiology preferentially recommend CHA2DS2-VASc, though CHADS2 remains widely used due to its simplicity and extensive validation.

When should anticoagulation be started based on CHADS2 score?

Anticoagulation recommendations based on CHADS2 score generally follow these guidelines: Score 0 indicates low risk (approximately 1.9% annual stroke rate), and aspirin alone (75-325 mg daily) or no therapy may be appropriate. Score 1 represents moderate risk (2.8% annual rate), where either aspirin or oral anticoagulation can be considered based on patient preference and bleeding risk. Score 2 or higher indicates that oral anticoagulation is recommended unless contraindicated, as the annual stroke risk exceeds 4%. Options include warfarin (target INR 2.0-3.0) or direct oral anticoagulants (DOACs) such as apixaban, rivarelbaan, dabigatran, or edoxaban. The bleeding risk (assessed with HAS-BLED score) should always be weighed against the stroke prevention benefit.

What are the limitations of the CHADS2 score?

The CHADS2 score has several recognized limitations. First, it classifies a large proportion of patients as intermediate risk (score 1), making treatment decisions uncertain for this group. Second, it does not account for several important stroke risk factors including vascular disease, age 65-74, and female sex, which are captured by the CHA2DS2-VASc score. Third, all included risk factors are weighted equally (except stroke), despite evidence that some factors carry higher risk than others. Fourth, it was validated primarily in North American and European populations and may not perform equally across all ethnic groups. Fifth, it does not incorporate bleeding risk assessment, so clinicians must separately evaluate contraindications to anticoagulation. Despite these limitations, its simplicity makes it useful for rapid bedside risk stratification.

How do I interpret the result?

Results are displayed with a label and unit to help you understand the output. Many calculators include a short explanation or classification below the result (for example, a BMI category or risk level). Refer to the worked examples section on this page for real-world context.

References

Reviewed by Rahul Singh, Health & Wellness Specialist ยท Editorial policy